Showing results (951-960 of 2,706) with videos related to

Sort By:
Pageof 271
The Lancet. Infectious Diseases|June 14, 2002
Epidemiology of chronic hepatitis C virus infection in sub-Saharan AfricaValsa Madhava, Christine Burgess, Ernest Drucker
The Lancet. Infectious Diseases|July 20, 2002
Treatment of human African trypanosomiasis--present situation and needs for research and developmentDominique Legros, Gaëlle Ollivier, Marc Gastellu-Etchegorry, et al.
The Lancet. Infectious Diseases|March 5, 2003
Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical managementMichael A Gardam, Edward C Keystone, Richard Menzies, et al.
The Lancet. Infectious Diseases|May 3, 2003
Clinical diagnosis of smear-negative pulmonary tuberculosis in low-income countries: the current evidenceKamran Siddiqi, Marie-Laurence Lambert, John Walley
The Lancet. Infectious Diseases|May 3, 2003
Taking malaria transmission out of the bottle: implications of mosquito dispersal for vector-control interventionsGerry F Killeen, Bart G J Knols, Weidong Gu
The Lancet. Infectious Diseases|March 28, 2013
Tuberculosis biomarkers discovery: developments, needs, and challengesRobert S Wallis, Peter Kim, Stewart Cole, et al.
The Lancet. Infectious Diseases|March 28, 2013
Engaging communities in tuberculosis researchRenaud F Boulanger, Stephanie Seidel, Erica Lessem, et al.
The Lancet. Infectious Diseases|March 23, 2013
AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trialJanet E McElhaney, Jiri Beran, Jeanne-Marie Devaster, et al.
The Lancet. Infectious Diseases|June 12, 2012
Combination of malaria vector control interventions in pyrethroid resistance area in Benin: a cluster randomised controlled trialVincent Corbel, Martin Akogbeto, Georgia B Damien, et al.
The Lancet. Infectious Diseases|June 2, 2012
Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144Merlin L Robb, Supachai Rerks-Ngarm, Sorachai Nitayaphan, et al.
Pageof 271